Overall survival of patients with relapsed and refractory multiple myeloma: adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone vs. high-dose dexamethasone
暂无分享,去创建一个
G. Morgan | M. Dimopoulos | A. Palumbo | J. Miguel | T. Facon | F. Offner | M. Zaki | K. Weisel | C. Jacques | L. Sternås | Xin Yu | S. Dhanasiri | Dawn Lee